US M&A and equity raisings

3,392 deals since January 2025, with sources and adviser credits where available · as at 20 Nov 2026 · Venture rounds

Deals dated after 30 September 2026 are still being collected.

Deal size
Custom range

445 deals · US$333bndisclosed · Healthcare · Clear

Columns
US M&A deals and equity raisings
Date Target Vendor Acquirer Type Status Value US$m Sector Advisers
Aug 2026 Alesta Therapeutics –BioMarin PharmaceuticalAcquisitionAnnounced275.0Biotech+2 J.P. Morgan (sell-side)Goodwin (sell-side)NautaDutilh (sell-side)Morgan Stanley (buy-side)Jones Day (buy-side)
Aug 2026 Weave Communications –Willow Parent, LLC (Francisco Partners)AcquisitionPending650.0Healthcare Software+2 Jefferies (sell-side)Orrick (sell-side)Kirkland & Ellis (buy-side)
Aug 2026 CheckedUp Rockbridge Growth EquityProvidence Equity PartnersAcquisitionAnnounced–Advertising and marketing+2 Debevoise & Plimpton (buy-side)Mintz (buy-side)Moelis & Company (sell-side)Greenberg Traurig (sell-side)Honigman (sell-side)
Aug 2026 Meadowbrook at Agoura Hills –SlateView CapitalAsset saleAnnounced–Real Estate+1 Sidley Austin (buy-side)
Aug 2026 Hicuity Health –DocGoAcquisitionAnnounced–Healthcare Services+1 TD Securities (sell-side)Stradling Yocca Carlson & Rauth (sell-side)Norton Rose Fulbright (buy-side)
Aug 2026 Slate Medicines –Fulcrum TherapeuticsMergerAnnounced–Biotech+1 Goodwin (buy-side)Cooley (sell-side)Wedbush Securities (sell-side)Leerink Partners (buy-side)
Aug 2026 Redx Pharma –Skye BioscienceAcquisitionAnnounced–Biotech+1 Wedbush Securities (sell-side)Cooley (sell-side)Stifel (buy-side)Morrison & Foerster (buy-side)
Aug 2026 MAIN5 –AstrixAcquisitionAnnounced–Pharma Services+1 Gibson Dunn (buy-side)
Aug 2026 Helix Advisory –EnableCompAcquisitionAnnounced–Healthcare Software+1 Greenberg Advisors (buy-side)
Aug 2026 Actio Biosciences –Jazz PharmaceuticalsAcquisitionAnnounced820.0Biotech+2 J.P. Morgan (sell-side)Centerview Partners (sell-side)Cooley (sell-side)Moelis & Company (buy-side)Hogan Lovells Cadwalader (buy-side)
Aug 2026 assets, business operations and customer relationships –NueCell BioAsset saleAnnounced–Pharma Services+1 Goodwin (buy-side)
Aug 2026 Varex Imaging –Teledyne TechnologiesAcquisitionAnnounced1,100.0Medtech+2 Evercore (sell-side)Orrick (sell-side)Latham & Watkins (buy-side)McGuireWoods (buy-side)
Aug 2026 Vital Connect –iRhythm HoldingsAcquisitionAnnounced287.5Medtech+1 Goodwin (sell-side)
Aug 2026 Smile America Partners Beach Point Capital Management LP–AcquisitionCompleted–Healthcare Services Dechert (sell-side)
Aug 2026 Cy Biopharma –Ensysce BiosciencesAcquisitionCompleted–Biotech+1 H.C. Wainwright & Co.Orrick (sell-side)Wedbush Securities (sell-side)Troutman Pepper Locke (buy-side)Tungsten Advisors (buy-side)
Aug 2026 TYRVAYA (varenicline solution) nasal spray 0.03 mg ViatrisHarrowAsset saleAnnounced30.0Pharma+1 Cravath, Swaine & Moore (sell-side)
Aug 2026 VitalConnect –iRhythm HoldingsAcquisitionAnnounced287.5Medtech Goldman Sachs (buy-side)Fenwick & West (buy-side)
Aug 2026 Alkeus Pharmaceuticals –Tarsus PharmaceuticalsAcquisitionAnnounced450.0Biotech+2 Jefferies (sell-side)Latham & Watkins (sell-side)Barclays (buy-side)Gunderson Dettmer (buy-side)
Aug 2026 Lantheus Holdings –Curium US HoldingsAcquisitionAnnounced8,000.0Radiopharmaceuticals+1 Morgan Stanley (sell-side)BofA Securities (sell-side)Solomon Partners (sell-side)Covington & Burling (sell-side)Ropes & Gray (sell-side)Jefferies (buy-side)J.P. Morgan (buy-side)PJT Partners (buy-side)Kirkland & Ellis (buy-side)Arnold & Porter (buy-side)
Aug 2026 Supernus Pharmaceuticals ––MergerAnnounced–Pharma Morgan Lewis (sell-side)Cantor Fitzgerald (sell-side)Wells Fargo Securities (sell-side)Saul Ewing (sell-side)Jefferies (buy-side)Piper Sandler (buy-side)Goodwin (buy-side)Citi (buy-side)
Aug 2026 Integer Holdings –KKRAcquisitionAnnounced5,700.0Medtech+2 Raymond James (buy-side)Goldman Sachs (sell-side)Davis Polk (sell-side)Centerview Partners (buy-side)Barclays (buy-side)Citi (buy-side)Kirkland & Ellis (buy-side)
Aug 2026 BWXT Medical business BWX TechnologiesNordic CapitalAsset salePending800.0Radiopharmaceuticals+2 Solomon Partners (sell-side)Stikeman Elliott (sell-side)Kirkland & Ellis (buy-side)McCarthy Tétrault (buy-side)
Aug 2026 AdaptHealth ––Joint ventureAnnounced–Healthcare Services+1 Guggenheim Securities
Aug 2026 Relevate Health Mountaingate Capital–AcquisitionCompleted–Pharma Services+2 Latham & Watkins (sell-side)
Aug 2026 MIMETAS –BRUKERAcquisitionCompleted–Life Sciences+1 Raymond James
Aug 2026 KREWE Anesthesia –CHG HealthcareAcquisitionCompleted–Healthcare Staffing Latham & Watkins (buy-side)
Aug 2026 Numantec –Goldman Sachs AlternativesAcquisitionAnnounced–Medtech+1 Latham & Watkins (buy-side)
Aug 2026 NovaBone Products HalmaIsto BiologicsAcquisitionCompleted60.0Medtech+1 Baird (buy-side)
Aug 2026 Teleflex Medical OEM –MontaguAcquisitionCompleted1,500.0Medtech+1 Raymond James
Aug 2026 Mindful Health Solutions –Radial HealthAcquisitionCompleted–Behavioral Health Edgemont Partners (sell-side)
Aug 2026 Everlight Radiology LivingbridgeRadiology PartnersAcquisitionAnnounced–Healthcare Services Allens (sell-side)Linklaters (sell-side)Jones Day (buy-side)
Aug 2026 Alafair Biosciences –Zimmer BiometAcquisitionAnnounced375.0Medtech Guggenheim Securities (sell-side)
Jul 2026 LogicMark –Langham ProjectMergerAnnounced1.5Consumer Electronics+1 Roth Capital Partners (sell-side)Sullivan & Worcester (sell-side)Manatt, Phelps & Phillips (buy-side)
Jul 2026 Neurimmune's royalty interest in AstraZeneca's cliramitug NeurimmuneRoyalty PharmaAsset saleAnnounced250.0Pharma+1 Goodwin (buy-side)
Jul 2026 Apex Infusion –SkyKnight Capital, L.P.StakeAnnounced–Healthcare Services Willkie Farr & Gallagher (sell-side)Arnold & Porter (sell-side)
Jul 2026 Synlogic ––MergerAnnounced–Biotech+1 Lucid Capital Markets (sell-side)Mintz (sell-side)Fenwick & West (buy-side)
Jul 2026 Avisoft Bioacoustics –Lafayette InstrumentAcquisitionCompleted–Life Sciences+2 Vedder Price (buy-side)RSM (buy-side)
Jul 2026 Sanara MedTech –MiMedx GroupAcquisitionAnnounced350.0Medtech Truist Securities (sell-side)Alston & Bird (sell-side)Centerview Partners (buy-side)Greenberg Traurig (buy-side)
Jul 2026 MYOS Corp –PetIQAcquisitionCompleted–Supplements+2 Davis Graham (sell-side)Davis Polk (buy-side)Lincoln International (buy-side)
Jul 2026 Vidya Therapeutics –Processa PharmaceuticalsAcquisitionCompleted–Biotech+1 Leerink Partners (sell-side)Cooley (sell-side)Tungsten Advisors (buy-side)Katten Muchin Rosenman (buy-side)
Jul 2026 Golden Gate Urology ––MergerAnnounced–Healthcare Services
Jul 2026 MAS Medical Staffing –Care CareerAcquisitionCompleted–Healthcare Staffing+1 The Braff Group (sell-side)
Jul 2026 Forte Biosciences –argenx SEAcquisitionAnnounced2,200.0Biotech+1 Guggenheim Securities (sell-side)Wilson Sonsini Goodrich & Rosati (sell-side)Goldman Sachs (buy-side)Freshfields (buy-side)Innisfree M&A (buy-side)
Jul 2026 OHB Pediatrics Ltd. d/b/a Oak Hill Bio –Research Alliance Corporation IIIMergerAnnounced–Biotech+2 Goodwin (sell-side)Leerink Partners (buy-side)Cooley (buy-side)
Jul 2026 KMM Group –RS2 Healthcare PartnersAcquisitionCompleted–Contract Manufacturing+1 Choate, Hall & Stewart (buy-side)
Jul 2026 ArisGlobal Nordic CapitalDassault SystèmesAcquisitionAnnounced2,000.0Healthcare Software+2 Evercore (sell-side)Jefferies (sell-side)Kirkland & Ellis (sell-side)Sullivan & Cromwell (buy-side)
Jul 2026 Neuphoria Therapeutics –Scancell HoldingsAcquisitionAnnounced–Biotech+1 H.C. Wainwright & Co. (sell-side)WG Partners (sell-side)Winston Taylor (sell-side)Leerink Partners (buy-side)Cooley (buy-side)
Jul 2026 The Skin Center Footbridge Partners–AcquisitionAnnounced–Medical Aesthetics+1 Mesirow (sell-side)
Jul 2026 BioLife Solutions –RepligenAcquisitionAnnounced1,500.0Life Sciences+1 Centerview Partners (sell-side)K&L Gates (sell-side)Goodwin (buy-side)Perella Weinberg Partners (buy-side)Goldman Sachs (buy-side)
Jul 2026 Northstar Dental Partners –DentalcorpAcquisitionAnnounced–Healthcare Services Weil, Gotshal & Manges (buy-side)

Deals come from SEC filings (merger proxies, tender offers, 8-K announcements and IPO prospectuses), the deal pages and transaction lists of law firms and banks, companies' press releases and the press. How the data is built